Tissue- and case-specific retention of intron 40 in mature dystrophin mRNA

Journal of Human Genetics

Volumn 60, Issue 6, 2015, Pages 327-333

  Nishida, Atsushi ^a   Minegishi, Maki ^b   Takeuchi, Atsuko ^b   Niba, Emma Tabe Eko ^a   Awano, Hiroyuki ^c   Lee, Tomoko ^d   Iijima, Kazumoto ^c   Takeshima, Yasuhiro ^d   Matsuo, Masafumi ^a  

^a KOBE GAKUIN UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d HYOGO COLLEGE OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE; DYSTROPHIN; GUANINE; MESSENGER RNA; ISOPROTEIN;

ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DNA BASE COMPOSITION; DUCHENNE MUSCULAR DYSTROPHY; DYSTROPHIN GENE; ELECTROPHORESIS; EXON; FEMALE; FETUS; FETUS LIVER; GENE; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; INTRON RETENTION; KIDNEY; LUNG; MALE; PLACENTA; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; SPLEEN; STOP CODON; TISSUE SPECIFICITY; ANTIBODY SPECIFICITY; GENETICS; INTRON; METABOLISM;

BASE COMPOSITION; DYSTROPHIN; HUMANS; INTRONS; KIDNEY; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, DUCHENNE; ORGAN SPECIFICITY; PROTEIN ISOFORMS; RNA, MESSENGER;

EID: 84932626750     PISSN: 14345161     EISSN: 1435232X     Source Type: Journal    
DOI: 10.1038/jhg.2015.24     Document Type: Article

References (45)

1. Singh, J. & Padgett, R. A. Rates of in situ transcription and splicing in large human genes. Nat. Struct. Mol. Biol. 16, 1128-1133 (2009
2. Suzuki, H., Kameyama, T., Ohe, K., Tsukahara, T. & Mayeda, A. Nested introns in an intron: evidence of multi-step splicing in a large intron of the human dystrophin premRNA. FEBS Lett. 587, 555-561 (2013
3. Black, D. L. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72, 291-336 (2003
4. Matlin, A. J., Clark, F. & Smith, C. W. Understanding alternative splicing: towards a cellular code. Nat. Rev. Mol. Cell Biol. 6, 386-398 (2005
5. Fu, X. D. & Ares, M. Jr. Context-dependent control of alternative splicing by RNA-binding proteins. Nat. Rev. Genet. 10, 689-701 (2014
6. Keren, H., Lev-Maor, G. & Ast, G. Alternative splicing and evolution: diversification, exon definition and function. Nat. Rev. Genet. 11, 345-355 (2010
7. Feener, C. A., Koenig, M. & Kunkel, L. M. Alternative splicing of human dystrophin mRNA generates isoforms at the carboxy terminus. Nature 338, 509-511 (1989
8. Surono, A., Takeshima, Y., Wibawa, T., Ikezawa, M., Nonaka, I. & Matsuo, M. Circular dystrophin RNAs consisting of exons that were skipped by alternative splicing. Hum. Mol. Genet. 8, 493-500 (1999
9. Sironi, M., Cagliani, R., Pozzoli, U., Bardoni, A., Comi, G. P. & Giorda, R. et al. The dystrophin gene is alternatively spliced throughout its coding sequence. FEBS Lett. 517, 163-166 (2002
10. Lareau, L. F., Green, R. E., Bhatnagar, R. S. & Brenner, S. E. The evolving roles of alternative splicing. Curr. Opin. Struct. Biol. 14, 273-282 (2004
11. Melhuish, T. A. & Wotton, D. The Tgif2 gene contains a retained intron within the coding sequence. BMC Mol. Biol. 7, 2 (2006
12. Khaladkar, M., Buckley, P. T., Lee, M. T., Francis, C., Eghbal, M. M. & Chuong, T. et al. Subcellular RNA sequencing reveals broad presence of cytoplasmic intron-sequence retaining transcripts in mouse and rat neurons. PLoS ONE 8, e76194 (2013
13. Galante, P. A., Sakabe, N. J., Kirschbaum-Slager, N. & De Souza, S. J. Detection and evaluation of intron retention events in the human transcriptome. RNA 10, 757-765 (2004
14. Zhang, Q., Li, H., Jin, H., Tan, H., Zhang, J. & Sheng, S. The global landscape of intron retentions in lung adenocarcinoma. BMC Med. Genomics 7, 15 (2014
15. Wong, J. J., Ritchie, W., Ebner, O. A., Selbach, M., Wong, J. W. & Huang, Y. et al. Orchestrated intron retention regulates normal granulocyte differentiation. Cell 154, 583-595 (2013
16. Takeshima, Y., Yagi, M., Okizuka, Y., Awano, H., Zhang, Z. & Yamauchi, Y. et al. Mutation spectrum of the dystrophin gene in 442 Duchenne/Becker muscular dystrophy cases from one Japanese referral center. J. Hum. Genet. 55, 379-388 (2010
17. Dwi Pramono, Z. A., Takeshima, Y., Surono, A., Ishida, T. & Matsuo, M. A novel cryptic exon in intron 2 of the human dystrophin gene evolved from an intron by acquiring consensus sequences for splicing at different stages of anthropoid evolution. Biochem. Biophys. Res. Commun. 267, 321-328 (2000
18. Ishibashi, K., Takeshima, Y., Yagi, M., Nishiyama, A. & Matsuo, M. Novel cryptic exons identified in introns 2 and 3 of the human dystroiphin gene with duplication of exons 8-11. Kobe J. Med. Sci. 52, 61-75 (2006
19. Zhang, Z., Habara, Y., Nishiyama, A., Oyazato, Y., Yagi, M. & Takeshima, Y. et al. Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons. J. Hum. Genet. 52, 607-617 (2007
20. Malueka, R. G., Takaoka, Y., Yagi, M., Awano, H., Lee, T. & Dwianingsih, E. K. et al. Categorization of 77 dystrophin exons into 5 groups by a decision tree using indexes of splicing regulatory factors as decision markers. BMC Genet. 13, 23 (2012).
21. Bovolenta, M., Erriquez, D., Valli, E., Brioschi, S., Scotton, C. & Neri, M. et al. The DMD locus harbours multiple long non-coding RNAs which orchestrate and control transcription of muscle dystrophin mRNA isoforms. PLoS ONE 7, e45328 (2012
22. Ahn, A. H. & Kunkel, L. M. The structural and functional diversity of dystrophin. Nat. Genet. 3, 283-291 (1993
23. Kubokawa, I., Takeshima, Y., Ota, M., Enomoto, M., Okizuka, Y. & Mori, T. et al. Molecular characterization of the 5′-UTR of retinal dystrophin reveals a cryptic intron that regulates translational activity. Mol. Vis. 16, 2590-2597 (2010
24. Sakabe, N. J. & De Souza, S. J. Sequence features responsible for intron retention in human. BMC Genomics 8, 59 (2007
25. Matsuo, M., Masumura, T., Nishio, H., Nakajima, T., Kitoh, Y. & Takumi, T. et al. Exon skipping during splicing of dystrophin mRNA precursor due to an intraexon deletion in the dystrophin gene of Duchenne muscular dystrophy. Kobe J. Clin. Invest. 87, 2127-2131 (1991
26. Nishida, A., Kataoka, N., Takeshima, Y., Yagi, M., Awano, H. & Ota, M. et al. Chemical treatment enhances skipping of a mutated exon in the dystrophin gene. Nat. Commun. 2, 308 (2011
27. Tran, V. K., Zhang, Z., Yagi, M., Nishiyama, A., Habara, Y. & Takeshima, Y. et al. A novel cryptic exon identified in the 3′ region of intron 2 of the human dystrophin gene. J. Hum. Genet. 50, 425-433 (2005
28. Shapiro, M. B. & Senapathy, P. RNA splice junctions of different classes of eukaryotes: sequence statistics and functional implications in gene expression. Nucleic Acids Res. 15, 7155-7174 (1987
29. Fairbrother, W. G., Yeh, R. F., Sharp, P. A. & Burge, C. B. Predictive identification of exonic splicing enhancers in human genes. Science 297, 1007-1013 (2002
30. Královicová, J. & Vorechovsky, I. Global control of aberrant splice-site activation by auxiliary splicing sequences: evidence for a gradient in exon and intron definition. Nucleic Acids Res. 35, 6399-6413 (2007
31. Zhang, J., Kuo, C. C. & Chen, L. GC content around splice sites affects splicing through pre-mRNA secondary structures. BMC Genomics 12, 90 (2011
32. Smith, L. D., Lucas, C. M. & Eperon, I. C. Intron retention in the alternatively spliced region of RON results from weak 3′ splice site recognition. PLoS ONE 8, e77208 (2013
33. Turano, M., Angrisani, A., Di Maio, N. & Furia, M. Intron retention: a human DKC1 gene common splicing event. Biochem. Cell Biol. 91, 506-512 (2013
34. Cho, V., Mei, Y., Sanny, A., Chan, S., Enders, A. & Bertram, E. M. et al. The RNA-binding protein hnRNPLL induces a T cell alternative splicing program delineated by differential intron retention in polyadenylated RNA. Genome Biol. 15, R26 (2014
35. Pimentel, H., Parra, M., Gee, S., Ghanem, D., An, X. & Li, J. et al. A dynamic alternative splicing program regulates gene expression during terminal erythropoiesis. Nucleic Acids Res. 42, 4031-4042 (2014
36. Wang, Y., Marino-Enriquez, A., Bennett, R. R., Zhu, M., Shen, Y. & Eilers, G. et al. Dystrophin is a tumor suppressor in human cancers with myogenic programs. Nat. Genet. 46, 601-606 (2014
37. Wahl, M. C., Will, C. L. & Luhrmann, R. The spliceosome: design principles of a dynamic RNP machine. Cell 136, 701-718 (2009
38. Talerico, M. & Berget, S. M. Intron definition in splicing of small Drosophila introns. Mol. Cell. Biol. 14, 3434-3445 (1994
39. Stamm, S., Zhu, J., Nakai, K., Stoilov, P., Stoss, O. & Zhang, M. Q. An alternative-exon database and its statistical analysis. DNA Cell Biol. 19, 739-756 (2000
40. Ohler, U., Shomron, N. & Burge, C. B. Recognition of unknown conserved alternatively spliced exons. PLoS Comput. Biol. 1, 113-122 (2005
41. Collesi, C., Santoro, M. M., Gaudino, G. & Comoglio, P. M. A splicing variant of the RON transcript induces constitutive tyrosine kinase activity and an invasive phenotype. Mol. Cell. Biol. 16, 5518-5526 (1996
42. Mendell, J. R., Province, M. A., Moxley, R. T. 3rd, Griggs, R. C., Brooke, M. H. & Fenichel, G. M. et al. Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls. Arch. Neurol. 44, 808-811 (1987
43. Brooke, M. H., Fenichel, G. M., Griggs, R. C., Mendell, J. R., Moxley, R. & Florence, J. et al. Duchenne muscular dystrophy: patterns of clinical progression and effects of supportive therapy. Neurology 39, 475-481 (1989
44. Desguerre, I., Christov, C., Mayer, M., Zeller, R., Becane, H. M. & Bastuji-Garin, S. et al. Clinical heterogeneity of duchenne muscular dystrophy (DMD): definition of sub-phenotypes and predictive criteria by long-term follow-up. PLoS ONE 4, e4347 (2009
45. Lidov, H. G. & Kunkel, L. M. Dystrophin and Dp140 in the adult rodent kidney. Lab. Invest. 78, 1543-1551 (1998